1984
DOI: 10.1073/pnas.81.8.2275
|View full text |Cite
|
Sign up to set email alerts
|

Variations in DNA methylation during mouse cell differentiation in vivo and in vitro.

Abstract: Mouse teratocarcinoma cells induced to differentiate in vitro undergo a massive (30%) demethylation of DNA. A similar undermethylation is also observed in the mouse extraembryonic membranes, the yolk sac and placenta. In both cases, the decrease in methyl moieties occurs at a large number of CpG sites spread out over the entire genome, as indicated by a restriction enzyme analysis of several mouse genes including dhfr, 13-major globin, and the H-2K gene family. In contrast to this, the embryo itself appears to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
91
3

Year Published

1988
1988
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 175 publications
(98 citation statements)
references
References 48 publications
4
91
3
Order By: Relevance
“…Some cancers can be induced to differentiate by cytokines that regulate the differentiation of normal cells, whereas other cancers can differentiate in response to a variety of compounds including retinoic acid, dexamethasone, cytosine arabinoside and others (Sachs, 1978(Sachs, , 1987a(Sachs, , b, 1995(Sachs, , 1996Lotem and Sachs, 2002a, b). The differentiation of cancer cells is associated with epigenetic reprogramming of their DNA and/or chromatin (Razin et al, 1984;Cairns, 2001;Hong et al, 2001;Zhu et al, 2001;Di Croce et al, 2002). In some cases cancer cell differentiation can be induced by inhibitors of DNA methyltransferases (Dore et al, 1998) and/or histone deacetylases (Cameron et al, 1999;Wang et al, 1999;Marks et al, 2001;Munster et al, 2001).…”
Section: Epigenetic Control Of Differentiation In Cancer Stem Cellsmentioning
confidence: 99%
“…Some cancers can be induced to differentiate by cytokines that regulate the differentiation of normal cells, whereas other cancers can differentiate in response to a variety of compounds including retinoic acid, dexamethasone, cytosine arabinoside and others (Sachs, 1978(Sachs, , 1987a(Sachs, , b, 1995(Sachs, , 1996Lotem and Sachs, 2002a, b). The differentiation of cancer cells is associated with epigenetic reprogramming of their DNA and/or chromatin (Razin et al, 1984;Cairns, 2001;Hong et al, 2001;Zhu et al, 2001;Di Croce et al, 2002). In some cases cancer cell differentiation can be induced by inhibitors of DNA methyltransferases (Dore et al, 1998) and/or histone deacetylases (Cameron et al, 1999;Wang et al, 1999;Marks et al, 2001;Munster et al, 2001).…”
Section: Epigenetic Control Of Differentiation In Cancer Stem Cellsmentioning
confidence: 99%
“…In mammals, DNA methylation mainly occurs at CpG dinucleotides, with approximately 60-90% of cytosines at these sites methylated (Razin et al 1984). CpG-rich DNA fragments, or CpG islands (Bird 1987), are preferentially located at the transcription start site of genes.…”
mentioning
confidence: 99%
“…Heterokaryon studies predict that such factors would be active even at late stages of differentiation (9), not just during the growth phase of the cell culture. It is also unlikely that the temperature-sensitive factor(s) mediates its activity by determining the methylation status of muscle-specific genes (44) (24) or by extracellular matrix interactions (33).…”
Section: Resultsmentioning
confidence: 99%